Novartis hopes to commercialise "smart lens" within 5 years
ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.
"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.
Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.
(Reporting by Caroline Copley and Paul Arnold.)
- Tweet this
- Share this
- Digg this
- Israel intensifies Gaza assault, Egyptians revise truce plan
- Chinese police shoot dead dozens after attack in Xinjiang
- Obama says strains over Ukraine not leading to new Cold War with Russia
- In rare move, Canada accuses Chinese of trying to hack govt network
- At least 43 Palestinians killed as Israel maintains pressure on Gaza
Twitter Inc halted a slowdown in user-growth in the second quarter with the help of product tweaks and services built around the summer's World Cup, assuaging concerns for now that the online messaging service had peaked. Full Article